EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY 4.0

Nodular Scleroderma in a Patient With Anti–RNA Polymerase III–Antibody Positive Systemic Sclerosis: A Case Report and Literature Review

Kyoko Kanno iD, Yuki Kobayashi, Yasuyuki Fujita iD

The Journal of Dermatology · 2026-08 · 53 (8) · 1213-1216

DOI: 10.1111/1346-8138.70391 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Dermatology, online erschienen am 12.07.2026. Verfasst von Kyoko Kanno und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan. Hauptthemen laut MEDLINE: Scleroderma, Systemic, RNA Polymerase III, Autoantibodies. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nodular scleroderma (NS) is a rare manifestation of systemic sclerosis (SSc) that can clinically resemble keloids, often leading to diagnostic difficulty. Herein we report a case of a 76‐year‐old woman with anti–RNA polymerase III antibody–positive SSc who developed progressive erythematous, pruritic, keloid‐like plaques 3 months after rituximab therapy. Histopathology showed thickened collagen bundles extending from the superficial to mid‐dermis, increased fibroblasts, mucin deposition, and reduced elastic fibers without the hyalinized collagen characteristic of keloids, confirming NS. To date, NS associated with anti‐RNA polymerase III antibody‐positive SSc has not been reported. The patient was treated with topical PUVA, resulting in reduction of pruritus and softening of nodular lesions. Review of Japanese and international cases indicates that NS commonly arises during active SSc, often in areas of mechanical stress, and shows variable therapeutic response. This case expands the serological spectrum of NS and supports PUVA as a therapeutic option for symptomatic lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicRNA Polymerase IIIAutoantibodiesHumansFemaleAgedPUVA TherapyRituximabSkinTreatment Outcome

Stichwörter der Autor:innen

PUVA therapyanti–RNA polymerase III antibodykeloidal lesionnodular sclerodermasystemic sclerosis

Substanzen

RNA Polymerase IIIAutoantibodiesRituximab

Autor:innen und Institutionen

  • Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.

ORCID-Profile: Kyoko Kanno, Yasuyuki Fujita

Zitieren

APA

Kanno, K., Kobayashi, Y., & Fujita, Y. (2026). Nodular Scleroderma in a Patient With Anti–RNA Polymerase III–Antibody Positive Systemic Sclerosis: A Case Report and Literature Review. The Journal of Dermatology, 53(8), 1213-1216. https://doi.org/10.1111/1346-8138.70391

Vancouver

Kanno K, Kobayashi Y, Fujita Y. Nodular Scleroderma in a Patient With Anti–RNA Polymerase III–Antibody Positive Systemic Sclerosis: A Case Report and Literature Review. The Journal of Dermatology. 2026;53(8):1213-1216. doi:10.1111/1346-8138.70391

BibTeX
@article{Kanno2026,
  author = {Kanno, Kyoko and Kobayashi, Yuki and Fujita, Yasuyuki},
  title = {Nodular Scleroderma in a Patient With Anti–RNA Polymerase III–Antibody Positive Systemic Sclerosis: A Case Report and Literature Review},
  journal = {The Journal of Dermatology},
  year = {2026},
  volume = {53},
  number = {8},
  pages = {1213--1216},
  doi = {10.1111/1346-8138.70391}
}
Kostenlos starten →